10 Best Get Rich Quick Stocks to Buy Now

3. Envoy Medical, Inc. (NASDAQ:COCH)

Upside potential as of July 8, 2025: 387.67%

Beta (5Y Monthly): 2.27

Envoy Medical, Inc. (NASDAQ:COCH) has disclosed that it has tapped into the remaining $5 million of principal available under its promissory note with GAT Funding, LLC, which is under the control of Glen Taylor, who happens to be a part of the company’s board of directors.

As the conditions of the additional draw, Envoy Medical, Inc. (NASDAQ:COCH) issued GAT Funding a warrant to acquire 750,000 shares of its Class A Common Stock, with an exercise price of $1.48 per share. This price is the same as the closing price of the stock on the date of the draw.

The shares associated with these warrants were issued via a private transaction based on exemptions from registration under Section 4(a)(2) of the Securities Act of 1933 and Rule 506 of Regulation D. In other news, Envoy Medical, Inc. (NASDAQ:COCH) has secured two new U.S. patents for its implantable hearing technology. There’s a good reason to believe that the company has a long way to go.

Envoy Medical, Inc. (NASDAQ:COCH) is a Minnesota-based hearing health company that offers medical technologies across the hearing loss spectrum. Founded in 1995, the company is committed to transforming the hearing industry.